BRPI1008822A2 - formulação de doramectina de alta dosagem - Google Patents
formulação de doramectina de alta dosagemInfo
- Publication number
- BRPI1008822A2 BRPI1008822A2 BRPI1008822A BRPI1008822A BRPI1008822A2 BR PI1008822 A2 BRPI1008822 A2 BR PI1008822A2 BR PI1008822 A BRPI1008822 A BR PI1008822A BR PI1008822 A BRPI1008822 A BR PI1008822A BR PI1008822 A2 BRPI1008822 A2 BR PI1008822A2
- Authority
- BR
- Brazil
- Prior art keywords
- high dosage
- doramectin
- formulation
- doramectin formulation
- dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15291109P | 2009-02-16 | 2009-02-16 | |
| US61/152.911 | 2009-02-16 | ||
| US21983709P | 2009-06-24 | 2009-06-24 | |
| US61/219.837 | 2009-06-24 | ||
| PCT/IB2010/050443 WO2010116267A1 (en) | 2009-02-16 | 2010-02-02 | High dosage doramectin formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1008822A2 true BRPI1008822A2 (pt) | 2016-03-08 |
| BRPI1008822B1 BRPI1008822B1 (pt) | 2019-04-09 |
Family
ID=42060687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008822-9A BRPI1008822B1 (pt) | 2009-02-16 | 2010-02-02 | Composição veterinária antiparasitária e uso da mesma |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8551962B2 (pt) |
| EP (1) | EP2396006B1 (pt) |
| JP (1) | JP2012517994A (pt) |
| KR (1) | KR101326428B1 (pt) |
| CN (1) | CN102316876B (pt) |
| AR (1) | AR075428A1 (pt) |
| AU (1) | AU2010233409B2 (pt) |
| BR (1) | BRPI1008822B1 (pt) |
| CA (1) | CA2750626C (pt) |
| CL (1) | CL2011001775A1 (pt) |
| CO (1) | CO6410307A2 (pt) |
| DK (1) | DK2396006T3 (pt) |
| ES (1) | ES2399228T3 (pt) |
| HK (1) | HK1161087A1 (pt) |
| MX (1) | MX2011008614A (pt) |
| NZ (1) | NZ594389A (pt) |
| PL (1) | PL2396006T3 (pt) |
| PT (1) | PT2396006E (pt) |
| WO (1) | WO2010116267A1 (pt) |
| ZA (1) | ZA201105310B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2867079A1 (en) | 2012-03-13 | 2013-09-19 | Bayer New Zealand Limited | Long acting compositions |
| ES2436249B1 (es) * | 2012-06-25 | 2014-06-23 | Javier Alberto ALONSO-VAQUERO VELASCO | Composición antiparasitaria para el control y tratamiento de parásitos de diferentes especies animales, caracterizada por combinar Moxidectina con las vitaminas: A, D3, y E |
| WO2014098623A1 (en) * | 2012-12-20 | 2014-06-26 | Alleva Animal Health Limited | Injectable eprinomectin formulation and anthelmintic use thereof |
| CN103977017B (zh) * | 2014-06-03 | 2016-09-07 | 重庆布尔动物药业有限公司 | 一种兽用抗寄生虫注射液及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8800986A1 (es) | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
| US6001822A (en) | 1989-04-11 | 1999-12-14 | Pfizer Inc. | Antiparasitic formulations |
| EP0393890B1 (en) * | 1989-04-11 | 1992-08-12 | Pfizer Limited | Injectable compositions containing 25-cyclohexyl-avermectin b1 |
| DE69636706T2 (de) * | 1995-09-25 | 2007-10-11 | Ashmont Holdings Ltd., Takapuna | Makrocyclische lacton anthelmintika |
| DE19613972A1 (de) | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
| EP0928136B1 (en) * | 1996-06-05 | 2003-10-22 | Ashmont Holdings Limited | Injectable compositions |
| DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
| US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
| KR20000025762A (ko) * | 1998-10-14 | 2000-05-06 | 유충식 | 이버멕틴류의 가용화 조성물 |
| GB9825402D0 (en) * | 1998-11-19 | 1999-01-13 | Pfizer Ltd | Antiparasitic formulations |
| GB9827727D0 (en) * | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| CN1304727A (zh) * | 2000-10-20 | 2001-07-25 | 王玉万 | 一种以苯甲酸苄酯或氮酮为助溶剂的含阿维菌素或伊维菌素的注射液 |
-
2010
- 2010-02-02 CA CA2750626A patent/CA2750626C/en not_active Expired - Fee Related
- 2010-02-02 PT PT107035198T patent/PT2396006E/pt unknown
- 2010-02-02 CN CN2010800079297A patent/CN102316876B/zh active Active
- 2010-02-02 DK DK10703519.8T patent/DK2396006T3/da active
- 2010-02-02 NZ NZ594389A patent/NZ594389A/xx not_active IP Right Cessation
- 2010-02-02 KR KR1020117021507A patent/KR101326428B1/ko not_active IP Right Cessation
- 2010-02-02 JP JP2011549707A patent/JP2012517994A/ja active Pending
- 2010-02-02 BR BRPI1008822-9A patent/BRPI1008822B1/pt active IP Right Grant
- 2010-02-02 PL PL10703519T patent/PL2396006T3/pl unknown
- 2010-02-02 MX MX2011008614A patent/MX2011008614A/es active IP Right Grant
- 2010-02-02 ES ES10703519T patent/ES2399228T3/es active Active
- 2010-02-02 EP EP10703519A patent/EP2396006B1/en not_active Not-in-force
- 2010-02-02 AU AU2010233409A patent/AU2010233409B2/en active Active
- 2010-02-02 WO PCT/IB2010/050443 patent/WO2010116267A1/en active Application Filing
- 2010-02-02 US US13/147,600 patent/US8551962B2/en not_active Expired - Fee Related
- 2010-02-15 AR ARP100100431A patent/AR075428A1/es active IP Right Grant
-
2011
- 2011-07-19 ZA ZA2011/05310A patent/ZA201105310B/en unknown
- 2011-07-21 CL CL2011001775A patent/CL2011001775A1/es unknown
- 2011-08-30 CO CO11111108A patent/CO6410307A2/es not_active Application Discontinuation
-
2012
- 2012-02-16 HK HK12101546.3A patent/HK1161087A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US8551962B2 (en) | 2013-10-08 |
| US20110294751A1 (en) | 2011-12-01 |
| PL2396006T3 (pl) | 2013-06-28 |
| ES2399228T3 (es) | 2013-03-26 |
| DK2396006T3 (da) | 2013-02-11 |
| CL2011001775A1 (es) | 2011-10-28 |
| PT2396006E (pt) | 2013-02-13 |
| AU2010233409A1 (en) | 2011-08-11 |
| CN102316876B (zh) | 2013-07-17 |
| CA2750626C (en) | 2013-10-01 |
| KR20110116231A (ko) | 2011-10-25 |
| EP2396006A1 (en) | 2011-12-21 |
| BRPI1008822B1 (pt) | 2019-04-09 |
| AU2010233409B2 (en) | 2012-05-17 |
| WO2010116267A1 (en) | 2010-10-14 |
| KR101326428B1 (ko) | 2013-11-20 |
| CA2750626A1 (en) | 2010-10-14 |
| AR075428A1 (es) | 2011-03-30 |
| CO6410307A2 (es) | 2012-03-30 |
| NZ594389A (en) | 2012-09-28 |
| JP2012517994A (ja) | 2012-08-09 |
| HK1161087A1 (en) | 2012-08-24 |
| EP2396006B1 (en) | 2012-12-19 |
| CN102316876A (zh) | 2012-01-11 |
| ZA201105310B (en) | 2012-09-26 |
| MX2011008614A (es) | 2011-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201400069B (it) | Formulazione farmaceutica | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| BRPI1006519A2 (pt) | formulação de anticorpos | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| IT1394860B1 (it) | Composti farmaceutici | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| BRPI1009465A2 (pt) | Formulação | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BRPI0922653A2 (pt) | preparação farmacêutica | |
| BR112013000356A2 (pt) | formulação farmacêutica injetável de malfalano | |
| BR112013013837A2 (pt) | derivados de substituição de imidazoquinolina | |
| BR112012005423A2 (pt) | formulação de hialuronano/esteroide estável | |
| BRPI1008403A2 (pt) | Formulação ectoparasiticida de odor melhorado | |
| BR112012001340A2 (pt) | composições farmacêuticas | |
| BR112012003149A2 (pt) | composição farmacêutica | |
| BRPI1006076A2 (pt) | composicoes farmaceuticas | |
| BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
| DK2642980T3 (da) | Pædiatrisk formulering | |
| BRPI1008822A2 (pt) | formulação de doramectina de alta dosagem | |
| SMT201500123B (it) | Dosaggio unitario di apadenoson | |
| BRPI0913940A2 (pt) | formulação de fenofibrato com biodisponibilidade oral aumentada | |
| SMT201600163B (it) | Formulazione alimentare comprendente glicogeno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: AH USA 42 LLC (US) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS LLC (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: ZOETIS SERVICES LLC (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: ZOETIS SERVICES LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/02/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/02/2010, OBSERVADAS AS CONDICOES LEGAIS |